Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TMUS vs MRNA✓SelectedUSD · MRNATMUS vs MRNA performance historyLatest closeAs of+1.89%11/20
Stock and ETF performance explorer

TMUS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+17.3%
MRNA return
+153.9%
Excess return
-136.6%
Maximum drawdown
-44.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.9%-2.2%+4.1%+1.8%
7D-2.6%-12.7%+10.1%-2.8%
30D+7.7%-20.7%+28.4%+7.3%
3M-8.1%+46.3%-54.4%-7.3%
6M-11.9%+305.2%-317.2%-7.5%
YTD-17.1%+561.2%-578.4%-10.8%
1Y-19.7%+772.1%-791.8%-12.8%
3Y+17.3%+147.0%-129.7%+24.5%
All+17.3%+153.9%-136.6%+24.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling